Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
2.02 (1y: +58%)
Market Cap 311 M P/E(ttm)
Enterprise Value 268.71 M P/B 3.72
NVAX- NAS (USA)
Novavax, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$2.02
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M311Revenue $M21.3Net Margin (%)-129.1Z-Score3.3
Enterprise Value $M268EPS $-0.2Operating Margin %-134.4F-Score3
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-129.1Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %-6.3Quick Ratio3.5Cash flow > EarningsY
Price/Sales12.65-y EBITDA Growth Rate %-22.5Current Ratio3.5Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-27.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-35.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M148ROI % (ttm)-41.7Gross Margin Increase y-yN

Gurus Latest Trades with NVAX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
NVAXJean-Marie Eveillard 2011-03-31 Sold Out $2.15 - $2.96
($2.44)		 $ 2.02-17%Sold Out0
NVAXJean-Marie Eveillard 2010-09-30 Add$2.01 - $2.34
($2.2)		 $ 2.02-8%Add 25%125,000
NVAXJean-Marie Eveillard 2010-06-30 Reduce$2.18 - $2.97
($2.46)		 $ 2.02-18%Reduce -52.65%100,000
NVAXJean-Marie Eveillard 2009-12-31 Buy 0.01%$2.53 - $4.41
($3.46)		 $ 2.02-42%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 4

NVAX is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Premium Most recent portfolio changes are included for Premium Members only!


NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
EVANS GARY CDirector 2013-04-24Sell79,000$2.45-17.55view
YOUNG JAMES FDirector 2013-03-11Buy100,000$2.03-0.49view
Hahn Timothy JonSVP, Manufacturing & PD 2012-05-14Buy30,000$1.3351.88view
Glenn Gregory MChief Scientific Officer 2012-05-10Buy25,000$1.3549.63view
DOUGLAS RICHARDDirector 2012-04-10Buy50,000$1.2166.94view
Glenn Gregory MChief Scientific Officer 2011-12-05Buy2,000$1.534.67view
YOUNG JAMES FDirector 2011-12-01Buy200,000$1.4638.36view
Glenn Gregory MChief Scientific Officer 2011-11-29Buy2,000$1.2660.32view
EVANS GARY CDirector 2011-08-23Sell691,376$1.2364.23view
Erck Stanley CPresident and CEO 2011-08-19Buy13,000$1.2660.32view

Press Releases about NVAX :

Quarterly/Annual Reports about NVAX:

News about NVAX:

symbol=NVAX Articles On GuruFocus.com
Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
Novavax Inc. Reports Operating Results (10-Q) May 11 2009 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK